Department Of General Surgery 2
51. Systematic Review and Meta-Analysis of Acute Mortality and Complication Rates Following Leadless Pacemaker Placement Using National-Level Data
52. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
53. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
54. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
55. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
56. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
57. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
58. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
59. Global health at crossroads: uniting together to overcome challenges, restore trust and advance priorities for a sustainable future
60. Mercury exposure, epigenetic modifications, and genetic susceptibility: insights from molecular docking and population analysis
61. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
62. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
63. Positive Effect of Platelet-Rich Plasma on Neoureterocystostomy in Rats: An Experimental Study
64. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
65. Immersive technologies as an innovative tool to increase academic success and motivation in higher education
66. From Mice to Primates: Assessing Hormone-Based Endometriosis Models for Preclinical and Therapeutic Insights
67. Mouse Brain Lymphatic Vessels
68. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
69. Attitude toward vaccination against COVID-19 and acceptance of the national QazVac vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey
70. Using BERT models for breast cancer diagnosis from Turkish radiology reports
71. Comparative effectiveness of endoscopic and microscopic adenoma removal in acromegaly
72. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
73. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
74. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
75. Uncovering Novel Anti-Lung Cancer Compounds: Insights from Marine Sponge-Derived Agents: A Bibliometric Review
76. Exploring the complex interplay of Blastocystis, morbid obesity, and bariatric surgery on gut microbial dynamics
77. Mini-invasive revascularization operations in the complex treatment of neuroischemic and ischemic forms of diabetic foot syndrome
78. Global burden of metabolic diseases, 1990–2021
79. Improving Fertility in Non-Obstructive Azoospermia: Results from An Autologous Bone Marrow-Derived Mesenchymal Stromal/Stem Cell Phase I Clinical Trial
80. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
81. Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021 (eClinicalMedicine (2024) 76, (S2589537024004279), (10.1016/j.eclinm.2024.102848))
82. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
1 2 2